TODAY'S MARKET INTELLIGENCE
Johnson & Johnson Raises 2026 Outlook, Q2 Sales Up 6.6% to $25.31B, Stock Jumps 3%
English summary
Johnson & Johnson reported second-quarter sales rose 6.6% to $25.31 billion and raised its full-year 2026 outlook, with shares climbing 3% on healthcare sector rotation. This reflects strong operational performance.
The English text is machine translated and may require verification against the Chinese version.
Browse today's intelligence